HC Wainwright & Co. Reiterates Buy on Adicet Bio, Maintains $10 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Edward White has reiterated a Buy rating on Adicet Bio (NASDAQ:ACET) and maintained a $10 price target.
March 20, 2024 | 4:18 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Adicet Bio maintains a Buy rating and a $10 price target from HC Wainwright & Co., indicating a positive outlook.
The reiteration of a Buy rating and maintenance of a $10 price target by a reputable analyst firm like HC Wainwright & Co. suggests a strong confidence in Adicet Bio's potential. This endorsement is likely to positively influence investor sentiment and could lead to an uptick in ACET's stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100